Variant report
Variant | nsv7915 |
---|---|
Chromosome Location | chr6:68251408-68270835 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:52)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr6:68268936-68269129 | K562 | blood: | n/a | n/a |
2 | ATF3 | chr6:68270050-68270268 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr6:68269989-68270319 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr6:68251426-68251964 | Hela-S3 | cervix: | n/a | n/a |
5 | CEBPB | chr6:68270047-68270243 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr6:68252417-68252737 | IMR90 | lung: | n/a | chr6:68252565-68252576 |
7 | CEBPB | chr6:68252483-68252740 | HepG2 | liver: | n/a | chr6:68252565-68252576 |
8 | CEBPB | chr6:68252543-68252704 | K562 | blood: | n/a | chr6:68252565-68252576 |
9 | CEBPB | chr6:68252469-68252626 | H1-hESC | embryonic stem cell: | n/a | chr6:68252565-68252576 |
10 | CHD2 | chr6:68270056-68270205 | K562 | blood: | n/a | n/a |
11 | CUX1 | chr6:68269013-68269169 | K562 | blood: | n/a | n/a |
12 | E2F4 | chr6:68257817-68258005 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | EP300 | chr6:68251364-68251864 | Hela-S3 | cervix: | n/a | chr6:68251364-68251378 chr6:68251629-68251643 |
14 | GATA2 | chr6:68268867-68269219 | K562 | blood: | n/a | n/a |
15 | GATA3 | chr6:68254601-68254741 | SH-SY5Y | brain: | n/a | n/a |
16 | JUN | chr6:68268730-68269122 | K562 | blood: | n/a | n/a |
17 | JUND | chr6:68270096-68270160 | K562 | blood: | n/a | n/a |
18 | JUND | chr6:68268985-68269133 | K562 | blood: | n/a | n/a |
19 | KAP1 | chr6:68254725-68255127 | K562 | blood: | n/a | n/a |
20 | KAP1 | chr6:68254552-68255328 | HEK293 | kidney: | n/a | n/a |
21 | KAP1 | chr6:68254611-68255232 | U2OS | brain: | n/a | n/a |
22 | MAFK | chr6:68265041-68265230 | HepG2 | liver: | n/a | n/a |
23 | MAX | chr6:68270037-68270192 | K562 | blood: | n/a | n/a |
24 | MAX | chr6:68270004-68270334 | K562 | blood: | n/a | n/a |
25 | MAX | chr6:68270004-68270347 | K562 | blood: | n/a | n/a |
26 | MYC | chr6:68270100-68270208 | K562 | blood: | n/a | n/a |
27 | POLR2A | chr6:68255287-68255295 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr6:68256529-68256653 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr6:68258071-68258110 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr6:68268901-68269133 | K562 | blood: | n/a | n/a |
31 | POLR2A | chr6:68268754-68268954 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr6:68252816-68252958 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr6:68269415-68269483 | Gliobla | brain: | n/a | n/a |
34 | POLR2A | chr6:68258398-68258491 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | RCOR1 | chr6:68268895-68269199 | K562 | blood: | n/a | n/a |
36 | RCOR1 | chr6:68270160-68270168 | K562 | blood: | n/a | n/a |
37 | SETDB1 | chr6:68254491-68255362 | U2OS | brain: | n/a | n/a |
38 | STAT3 | chr6:68254074-68254236 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | STAT3 | chr6:68262977-68262993 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | TAL1 | chr6:68268835-68269166 | K562 | blood: | n/a | n/a |
41 | TBL1XR1 | chr6:68270153-68270256 | K562 | blood: | n/a | n/a |
42 | TCF7L2 | chr6:68261556-68261854 | MCF-7 | breast: | n/a | chr6:68261731-68261745 |
43 | TCF7L2 | chr6:68251526-68251798 | Hela-S3 | cervix: | n/a | n/a |
44 | TEAD4 | chr6:68268762-68269257 | K562 | blood: | n/a | n/a |
45 | TEAD4 | chr6:68268784-68269207 | K562 | blood: | n/a | n/a |
46 | USF1 | chr6:68270009-68270386 | K562 | blood: | n/a | chr6:68270171-68270182 |
47 | USF1 | chr6:68260604-68260665 | GM12878 | blood: | n/a | n/a |
48 | USF1 | chr6:68270100-68270266 | HepG2 | liver: | n/a | chr6:68270171-68270182 |
49 | USF1 | chr6:68270046-68270381 | K562 | blood: | n/a | chr6:68270171-68270182 |
50 | USF2 | chr6:68270164-68270228 | Hela-S3 | cervix: | n/a | chr6:68270171-68270182 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-280P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568405017 | chr6:68251428-68251429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113245573 | chr6:68251489-68251490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544764140 | chr6:68251491-68251492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149319144 | chr6:68251515-68251516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373810789 | chr6:68251516-68251517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145107579 | chr6:68251566-68251567 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs544047258 | chr6:68251576-68251577 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs564187651 | chr6:68251609-68251610 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs553067735 | chr6:68251613-68251614 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs370332104 | chr6:68251635-68251636 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs572831502 | chr6:68251658-68251659 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs541859555 | chr6:68251703-68251704 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs144561905 | chr6:68251747-68251748 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs148454475 | chr6:68251780-68251781 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs12205461 | chr6:68251799-68251800 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs377606766 | chr6:68251819-68251820 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs142585281 | chr6:68251867-68251868 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs12206848 | chr6:68251903-68251904 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs146455961 | chr6:68251908-68251909 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs182237968 | chr6:68251910-68251911 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs60645711 | chr6:68251913-68251914 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs114112250 | chr6:68251920-68251921 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs531707312 | chr6:68251929-68251930 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs528529508 | chr6:68251942-68251943 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs550907215 | chr6:68251949-68251950 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs115248140 | chr6:68251966-68251967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539650025 | chr6:68251973-68251974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12213821 | chr6:68252008-68252009 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs113372436 | chr6:68252012-68252013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186267133 | chr6:68252049-68252050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374538204 | chr6:68252066-68252067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554998379 | chr6:68252072-68252073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs367675125 | chr6:68252079-68252080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368491245 | chr6:68252109-68252110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139840699 | chr6:68252138-68252139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116926228 | chr6:68252143-68252144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190685853 | chr6:68252145-68252146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560026758 | chr6:68252158-68252159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183396813 | chr6:68252172-68252173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527402912 | chr6:68252184-68252185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560529753 | chr6:68252274-68252275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143190989 | chr6:68252290-68252291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78762180 | chr6:68252297-68252298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78575385 | chr6:68252325-68252326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571062980 | chr6:68252345-68252346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146654941 | chr6:68252391-68252392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551779853 | chr6:68252411-68252412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144145706 | chr6:68252439-68252440 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs201207635 | chr6:68252456-68252457 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs140506812 | chr6:68252457-68252458 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:68251200-68252000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
2 | chr6:68251800-68253000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr6:68252000-68252400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr6:68266200-68272800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr6:68268600-68268800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr6:68268800-68269000 | Enhancers | K562 | blood |
7 | chr6:68269000-68270000 | Weak transcription | K562 | blood |
8 | chr6:68269400-68269600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr6:68270000-68270400 | Flanking Active TSS | K562 | blood |
10 | chr6:68270400-68274600 | Weak transcription | K562 | blood |